2017 San Antonio Breast Cancer Symposium Coverage

Save as Favorite
Sign in to receive recommendations (Learn more)
SABCS 2017

Every December, the San Antonio Breast Cancer Symposium brings together clinicians, researchers, and advocates to discuss the latest breast cancer study results. We’re proud to present our coverage below. We’ll be adding updates and links to the top of this page.




Research News

Study Suggests Intensifying Chemotherapy Improves Outcomes for Women With Early-Stage Disease, Jan. 10, 2018

Very Early Study Hints That Keytruda May Offer Benefits for Certain Metastatic HER2-Positive Breast Cancers, Jan. 9, 2018

Younger Women Report High Rate of Arm Problems 1 Year After Breast Cancer Diagnosis, Jan. 4, 2018

Extending Aromatase Inhibitor Treatment for 5 More Years No Better Than 2 More Years, Jan. 3, 2018

Temporary Ovarian Suppression May Help Preserve Fertility During Chemotherapy, Jan. 2, 2018

Acupuncture Eases Joint Pain Caused by Aromatase Inhibitors Dec. 21, 2017

Experimental Talazoparib Seems Better Than Chemotherapy for Metastatic HER2-Negative Disease in Women With a BRCA Mutation, Dec. 20, 2017

Kisqali Can Help Treat Younger Women With Metastatic Hormone-Receptor-Positive Disease, Dec. 19, 2017

Overweight Postmenopausal Women Who Lose Modest Amount of Weight Have Lower Breast Cancer Risk, Dec. 16, 2017

Podcasts

Ovarian Suppression Can Help Protect Ovarian Function and May Preserve Fertility in Younger Women Being Treated with Chemotherapy
Matteo Lambertini, M.D.

Acupuncture Helps Ease Joint Pain Caused by Aromatase Inhibitors
Dawn Hershman, M.D.

Experimental Talazoparib Seems Better Than Chemotherapy for Metastatic HER2-Negative Disease in Women With a BRCA Mutation
Jennifer Litton, M.D.

Raising Awareness of Inflammatory Breast Cancer -- Heard in the Halls: Voices From the 2017 San Antonio Breast Cancer Symposium
Terry Arnold

Postmenopausal Women Who Lose Modest Amount of Weight Have Lower Breast Cancer Risk
Rowan Chlebowski, M.D., Ph.D.

The Serenity Project: This Is Metastatic Breast Cancer -- Heard in the Halls: Voices From the 2017 San Antonio Breast Cancer Symposium
Kelly Shanahan, M.D.

Where Are We With Immunotherapy to Treat Breast Cancer? -- Heard in the Halls: Voices From the 2017 San Antonio Breast Cancer Symposium
Leisha Emens, M.D., Ph.D.

Kisqali in Combination with Hormonal Therapy and Ovarian Suppression Effective Treatment for Metastatic Hormone-Receptor-Positive, HER2-Negative Disease in Premenopausal Women: 2017 SABCS
Debu Tripathy, M.D.

The Metastatic Breast Cancer Alliance: Looking Forward -- Heard in the Halls: Voices From the 2017 San Antonio Breast Cancer Symposium
Marc Hurlbert


Was this article helpful? Yes / No


Springappeal18 miniad final
Back to Top